Insider Transactions in Q1 2021 at Deciphera Pharmaceuticals, Inc. (DCPH)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2021
|
Steven L. Hoerter President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,150
-3.64%
|
$132,300
$42.79 P/Share
|
|
Mar 01
2021
|
Michael Douglas Taylor Director |
SELL
Open market or private sale
|
Direct |
8,000
-93.1%
|
$352,000
$44.31 P/Share
|
|
Mar 01
2021
|
Michael Douglas Taylor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+50.0%
|
$8,000
$1.89 P/Share
|
|
Feb 16
2021
|
Matthew L Sherman EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,100
+18.66%
|
-
|
|
Feb 16
2021
|
Matthew L Sherman EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
132
-0.35%
|
$6,336
$48.87 P/Share
|
|
Feb 16
2021
|
Daniel Lee Flynn Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,100
+38.63%
|
-
|
|
Feb 16
2021
|
Daniel Lee Flynn Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
508
-7.22%
|
$24,384
$48.87 P/Share
|
|
Feb 16
2021
|
Thomas Patrick Kelly Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,100
+38.65%
|
-
|
|
Feb 16
2021
|
Thomas Patrick Kelly Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
524
-7.44%
|
$25,152
$48.87 P/Share
|
|
Feb 01
2021
|
Michael Douglas Taylor Director |
SELL
Open market or private sale
|
Direct |
8,000
-72.83%
|
$360,000
$45.31 P/Share
|
|
Feb 01
2021
|
Michael Douglas Taylor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+50.0%
|
$8,000
$1.89 P/Share
|
|
Jan 21
2021
|
Steven L. Hoerter President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,078
+2.4%
|
$26,950
$25.4 P/Share
|
|
Jan 15
2021
|
James Arthur Bristol |
SELL
Open market or private sale
|
Direct |
7,000
-95.71%
|
$350,000
$50.66 P/Share
|
|
Jan 15
2021
|
James Arthur Bristol |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$21,000
$3.95 P/Share
|
|
Jan 04
2021
|
Michael Douglas Taylor Director |
SELL
Open market or private sale
|
Direct |
19,000
-71.92%
|
$1,064,000
$56.63 P/Share
|
|
Jan 04
2021
|
Michael Douglas Taylor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+50.0%
|
$19,000
$1.89 P/Share
|